Citigroup Downgrades Agilon Health to Sell, Raises Price Target to $105
Benzinga Newsdesk 3 months ago
NewsDowngradesAnalyst RatingsPrice Target
Citigroup analyst Daniel Grosslight downgrades Agilon Health (NYSE:AGL) from Neutral to Sell and raises the price target from $80 to $105.
Citigroup analyst Daniel Grosslight downgrades Agilon Health (NYSE:AGL) from Neutral to Sell and raises the price target from $80 to $105.